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Summary 
The kinetics of acid release by a mixture of T  cells  and antigen presenting cells were measured 
with a microphysiometer during a brief exposure to antigenic peptides.  We find that some of 
the  early biochemical events  that lead to cellular proliferation  cause a specific increase  in the 
rate of acid release. The duration of this increase in acid release reflects the life-time of the pep- 
tide-MHC complexes. Peptides that form long-lived complexes produce a response that is sta- 
ble for more than  an hour.  Serial TCR  engagement is suggested by the  observation that the 
amplitude of this stable response can be rapidly shifted up or down with additional agonist pep- 
tide  or with  antibodies  that block T  cell receptor binding.  Cells briefly exposed to a peptide 
that forms short-lived peptide-MHC  complexes produce a response that decays rapidly as pep- 
tide is washed away. A  quantitative analysis of the kinetics of this decay in acidification demon- 
strates that intercellular TCR-ligand reactions are rapid, reversible, and of low apparent affinity 
with <20% ofpeptide-MHC  ligand bound to a TCR  at any one time.  These results demon- 
strate that the fraction ofpeptide-MHC ligands bound to TCRs at the cell-cell interface is no 
higher than anticipated from the affinities observed in solution for isolated TCRs and ligands. 
M 
any cellular recognition events involve specific inter- 
actions  of receptor-ligand  pairs  at  a  cell-cell  inter- 
face. It has been found that the binding affinities for these 
receptor-ligand pairs are often low when the molecules are 
isolated  and  studied  in solution  (1).  However,  intermem- 
brane molecular events are approximately two-dimensional 
and  involve  additional  adhesion  molecules  (2).  Thus,  the 
fraction ofligands bound to receptors at the cell-cell inter- 
face  (i.e.,  the  apparent affinity)  might differ from that ex- 
pected from the affinities measured in solution.  To address 
this  issue,  we  have  studied  the  reactions  of TCRs  with 
their ligands at the cell-cell interface.  The ligands are pep- 
tides  bound  to  MHC  proteins.  The  reactions  of isolated 
TCRs and  their ligands  in solution are characterized with 
affinities in the range of 0.1-40 IxM (3-7). 
The rate of acid release,  as measured with a microphysi- 
ometer, is a sensitive monitor of metabolic responses to ex- 
tracellular ligands (8,9).  Addition of antigenic peptide to a 
mixture  of T  cells  and APCs results  in  an increase  in  the 
acid release  due  to  the  interaction  of new peptide-MHC 
complexes on the APCs with specific TCRs on the T  cells 
(10).  During  initial  peptide  exposure,  the  rate  of this  in- 
crease  is  related  to  the  formation  of peptide-MHC  com- 
plexes and binding of these complexes to TCP,.s. If the cells 
are only briefly exposed to peptide and then washed to re- 
move  unbound  material,  new  peptide-MHC  complexes 
are no longer formed and changes in the  response  are  di- 
rectly related to the reactions of peptide-MHC  complexes 
with TCRs at the cell-cell interface. We have used this lat- 
ter feature  to study the  apparent  affinities  and  kinetics  for 
TCP,-ligand reactions at the cell-cell interface. 
Materials  and Methods 
Peptides.  The peptides  myelin basic protein (MBP) Ac(i-14), 
ASQKRPSQRHGSKY,  moth  cytochrome  c  (MCC)  88-103, 
ANERADLIAYLKQATK, and analogues  were synthesized  with 
standard FMOC chemistry, purified by reverse phase HPLC (Vy- 
dac C~8, acetonitrile/water)  and characterized by mass spectrometry. 
Cell Lines.  The MCC-specific SC.C7  T  cells were  derived 
from the  5C.C7  eq3-TCtL transgenic  mouse  (11). Spleen  cells, 
initially  primed with  10 p~M MCC and expanded for 8 d, were 
restimulated  with irradiated  (3,000  rad) B10.Blq. spleen  cells and 
MCC.  After 10 d of culture in the presence of IL-2, cells were 
sorted CD4 +. The MBP-specific B10A.F2 T  cell clone was ob- 
tained from lymph node cells harvested B10.A mice immunized 
subcutaneously at the base of  the tail with 200 p~g rat MBP Ac(1-11) 
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tuberculosis H37Ra  (Difco Laboratories,  Detroit,  MI).  The  cells 
were  stimulated  with  40  I~M  MBP  Ac(1-11)  and  irradiated 
(3,000  tad)  B10.A spleen cells three times (8-10-d intervals) and 
then cloned by limiting dilution. 
Microphysiometry.  Acid release was measured as described pre- 
viously  (10).  Briefly,  T  cells  rested  from  stimulation  (7-12  d) 
were combined with APCs that  had been cultured overnight in 
RPMI  1640  medium  containing  5% fetal calf serum.  APCs in- 
cluded Chinese hamster ovary (CHO)  cells transfected  (12)  with 
I-E  k, murine L cells transfected (13) with I-A  k, CH27 B-cell lym- 
phomas  and  B10.BR  splenocytes.  Cells  (3-6  X  10 ~') mixed at  a 
ratio of 20 T  cells to 1 APC were collected by centrifugation and 
resuspended in 105 p~L medium which was then mixed with 35 b~L 
of melted low-temperature-melting  agarose  at  37~  The  agar- 
ose-cell mixture (10 txL) was immediately spotted onto the mem- 
brane  of a  Cytosensor  cell capsule  (Molecular Devices, Sunny- 
vale,  CA).  After  10  min,  the  cell  capsule  was  assembled  and 
loaded  in  the  microphysiometer  chamber  maintained  at  37~ 
The chamber was perfused  (50  gtL/min) with low buffer RPMI 
1640  medium  containing  1  mM  sodium  phosphate,  1  mg/mL 
endotoxin-free  bovine  serum  albumin  (Calbiochem-Novabio- 
chem, San Diego, CA) and no bicarbonate (pH 7.4). Extracellular 
acidification rates were determined with 20 s potentiometric rate 
measurements after a 58-s pump  cycle and  10-s delay (90 s total 
cycle  time).  Maximal  responses  to  antigenic  peptide  typically 
ranged from 150-200% of the initial basal acidification rates  (60- 
100 txV s  i). Variations in maximal rates between different cham- 
bers during a single experiment were less than 10%. 
Cell Proliferation.  Proliferation of 5C.C7 T  cells (3 X  104) in- 
cubated with irradiated (3,000 rad) B10.BR spleen cells (5 X  105) 
and peptide was measured as the uptake of [3H]thymidine (1 p, Ci/ 
well).  Maxinmm  proliferation  ('~1  IxM  MCC)  was  "-,10  s  cpm 
with a background ,'ol ()3 cpm (no peptide). No counts above back- 
ground were observed for incubations with MCC-99R, -99Q, or 
-99E  at  concentrations  ~<50 txM.  Proliferation  of B10.AF2  T 
cells was measured using irradiated B10.A spleen cells. 
Results and Discussion 
Antigen  activation  of I-E  k restricted  5C.C7  T  cells  de- 
rived from the 5C.C7 ot~.-TCR transgenic mouse (11) was 
evaluated with a microphysiometer. Addition of MCC  pep- 
tide  to  a  mixture  of 5C.C7  T  cells and APCs  results  in an 
increase  in  the  rate  of acid production  within  minutes  of 
peptide  addition  (Fig.  1  a).  Inhibition  of the  response  by 
amiloride  (Fig.  1  a)  demonstrates  that  the  initial  response 
involves the Na+/H §  antiport which is frequently activated 
by  cellular  stimuli  (14).  The  MCC-99R,  -99E,  and  99Q 
peptides are single amino acid mutants modified at a 5C.C7 
TCR  contact  (15).  Each  of these  forms  a  stable  complex 
with  the  I-E  k MHC  protein  (16).  However,  only  the  na- 
tive MCC  peptide causes the proliferation of 5C.C7 T  cells 
(Materials and Methods)  or an acidification response (Fig. 1). 
It  has  been  demonstrated  that  anti-MHC  antibodies  can 
disrupt  intracellular Ca  2+  fluxes and T  cell proliferation  (4, 
17).  We  observe  that  the  I-Ek-specific  14-4-4S  antibody 
(18),  but  not I-Ak-specific antibody,  can block acid release 
by a  mixture  of 5C.C7  T  cells and  APCs  that  have previ- 
ously responded to peptide; the acidification response is re- 
gained if antibody is washed out (data not shown).  We also 
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Figure 1.  Antigenic peptide  produces  a specific increase in the rate of 
acid production for a mixture ofT cells and APCs. (a) The initial acidifi- 
cation response oft  cells from the 5C.C7 ~[3-TCR transgenic mouse to 
antigenic peptide  (MCC) is partly blocked by amiloride, a Na+/H + anti- 
port inhibitor.  Shown are the acidification rates tbr a mixture of 5C.C7 T 
cells and APCs  (20:l)  during  continuous  exposure  to (O) 4 p~M MCC, 
(0) 4 p~M MCC +  5 b~M hexamethylene  amiloride, (g3) 5 p~M hexame- 
thylene  amiloride,  (A)  4 btM MCC-99R peptide,  and  (A) media,  Re- 
agents were added at t =  0 rain (arrow)  and each data point corresponds to 
a 20 s acidification rate measurement  recorded every 9() s. Acidification 
rates are normalized to the basal rates at t =  0 rain  (100%). CH27 B cell 
lymphomas were used as APCs. No increase in acidification was noted in 
response to the MCC-99Q or 99E peptides in multiple independent ex- 
periments (data not shown). (b) The proliferation  (I-1) and microphysiom- 
eter  (0,￿9  dose  responses of 5C.C7  T  cells to  MCC.  Proliferation  is 
measured as uptake  of [3H]thymidine  and nficrophysiometer  response is 
measured as the % increase in acidification rate after 30 rain of continuous 
exposure  to peptide.  Proliferation  and % acidification are normalized  to 
the corresponding  maximum  responses: (~)  1.55 ￿  l0  s cpm,  (0)  121% 
and (￿9  159'/,,. B10.BR spleen cells were used as APCs for proliferation; 
(0)  CHO cells transfected  with  I-E  k and  (O)  CH27 cells were used as 
APCs  for  the  acidification  dose  responses. Acidification  responses pro- 
duced with spleen and CH27 cells are comparable (data not shown). 
compared  the  proliferation  and  microphysiometer  MCC 
dose responses of the 5C.C7 T  cell line (Fig.  1 b).  The pro- 
portional  slopes of the acidification and proliferation dose- 
response plots suggest that the initial response is a  quantita- 
tive  measure  of some  early  biochemical  event  related  to 
cellular proliferation.  The dose microphysiometer response 
is relatively insensitive to different APCs  (Fig.  1 b). 
A  steady  state  of signals  due  to  serial TCR  engagement 
(19)  is suggested  by  the  sustained  signaling  of T  cells after 
peptide  exposure.  Brief exposure  (90 s)  of a mixture of the 
5C.C7  T  cells and  APCs  to  the  MCC  peptide  produces  a 
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Figure  2.  A  sustained  T-cell acidification  response  is maintained  by 
steady state triggering ofTCRs. (a) Shown are the acidification rates of a 
mixture of 5C.C7 T cells and APCs in response to (￿9  1 nM, (am) 10 nM, 
(1~) 100 nM, (~) 1 I~M MCC peptide and (Z%) media added for 90 s (first 
two arrows). At t  =  45 nfin, the chamber  that  had been exposed  to 10 
nM peptide (I) was perfused with 100 nM MCC peptide for another 90 s 
(second two arrows).  (b) An expanded  view of data from a showing the 
increase  in  acidification  during  the  second  90-s  exposure  to  peptide. 
CHO cells transfected with I-E  k were used as APCs. 
rapid  increase  in  acid  production  that  remains  at  a  stable 
plateau  for more  than an hour  (Fig. 2  a).  After 45  rain,  an 
additional  pulse  (90  s)  of a  higher  concentration  of MCC 
peptide  causes  a  rapid  (90-180  s)  increase  to  a  higher pla- 
teau  (Fig.  2  a).  The  plateau  attained  after the second pulse 
(I00  nM  MCC)  is  the  same  as  that  attained  by  a  single 
pulse  of 100  nM  MCC  peptide  (Fig.  2  a).  Evidently the T 
cell response  to  peptide  is not  decreased by  prior  stimula- 
tion during the first hour of stimulation.  The increase after 
the  second  pulse  stabilizes  1-2  rain  after peptide  has  been 
washed  out  (Fig.  2  b).  This  duration  is independent  of the 
peptide  concentration  used  in  the  second  pulse  (data  not 
shown).  Control  experiments  in  which  pH  is  monitored 
during  introduction  and  removal  of pepfides  show  that 
peptide diffusion through the microphysiometer chamber is 
fast.  The  chamber  can  be  completely  saturated  with  or 
rinsed  free  of peptide  in  less  than  20  s  (data  not  shown). 
The time required to reach a  new plateau after excess pep- 
tide is completely removed, about  1-2 rain, is thus likely to 
be  an  upper  limit  for  the  time  constants  for  the  TCR- 
ligand binding and dissociation reactions. 
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Figure 3.  Short-lived peptide--MHC complexes produce  a transient in- 
crease in T  cell acidification.  (a) The increase in acid release is propor- 
tional to the log of peptide  concentration  (see also Fig. 1 b). Shown are 
acidification  dose  responses for B10A.F2  T  cells exposed  to  (￿9  MBP 
Ac(1-14) and (A) Ac(]-14)4A norn~alized to the %, acidification after 30 
n~n  exposure  to the at maximum pepfide  concentration.  Half-maximal 
proliferation  for MBP Ac(1-14)  and Ac(1-I4)4A is obtained  at peptide 
concentrations  of 10  I~M and  1 nM, respectively.  (b)  The acidification 
rates ofa mLxture ofBI0A.F2 T cells and APCs briefly exposed to (O)  10 
IxM MBP  Ac(1-14)4A,  (0)  100  /~M MBP Ac(1-14),  and  (Z%) media. 
Peptide  was added at t  =  0 rain  (first arrow); at t =  15 rain  (second ar- 
row)  peptide  addition  was stopped  and  the  chamber  was  continuously 
pet'fused with media.  (c) The long-lived T  cell response to MBP Ac(1- 
14)4A is sustained by active TCR ligation.  Mixtures  of B10A.F2 T cells 
and APCs were exposed to (Qs  1 ~M MBP Ac(1-14)4A or (z~) 
media for 30 rain.  10 I-~g/mL of the l-ALspecific  10-2.16 az~tibody was 
added (Q) immediately,  (E3) 30 min, and (A) 60 rain after peptide  expo- 
sure (first, second,  and third  arrows,  respectively).  Identical results were 
also obtained with 1 and I00 p~g/mL 10-2.16 antibody  (data not shown). 
L cells transfected with I-A  k were used as APCs. 
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lived peptide-MHC complexes provide further insight into 
TCR-ligand  interactions  at  the  cell-cell  interface.  The 
NH2-terminal MBP peptide is a murine autoantigenic pep- 
tide  that  forms  short-lived  complexes  with  the  I-A  u and 
I-A  k MHC  proteins  (20,  21).  The  peptide  in  which  the 
lysine at position-4 is substituted with alanine,  MBP Ac(1- 
14)4A,  dissociates  from detergent-soluble  (21)  or cell sur- 
face  I-A  k  (K.  Tate  and  P.  P.  Jones,  unpublished  results) 
with  tl/2  =  30 min.  Presumably dissociation  of the  native 
MBP Ac(1-14) peptide from I-A  k is much faster (i.e.,  tl/2  = 
r  min) since binding of the native peptide to I-A  k is not 
detected with these methods  (21).  Half-maximal prolifera- 
tion of the MBP-specific T  cell clone B10A.F2 with MBP 
Ac(1-14) and Ac(1-14)4A is obtained at peptide concentra- 
tions of 10 IzM and 1 nM, respectively. These large differ- 
ences in proliferation  dose  response  are  at  least  partly  ex- 
plained by differences in the peptide affinities for the MHC 
protein  I-A  k.  It is notable  that  the  half-maximal  acidifica- 
tion  responses  for these  two  peptides  also  differ by about 
four orders  of magnitude  (Fig.  3  a).  This  further  demon- 
strates  the  similarity  of proliferation  and acidification  dose 
responses. 
A  10-min exposure of a mixture of the B10A.F2 T  cells 
and  APCs  to  the  MBP  Ac(1-14)4A  peptide  produces  a 
rapid increase in acid production that slowly decays as the 
peptide is washed out (Fig. 3 b). The response to the native 
MBP  Ac(1-14)  peptide  decays  even  more  rapidly  as  the 
peptide is washed out (Fig. 3 b). In contrast, the response of 
5C.C7 T  cells briefly exposed to MCC is sustained despite 
continual perfusion of the cells with media  (Fig.  2).  These 
differences  are  consistent  with  the  observation  that MCC 
forms  a  long-lived  peptide-MHC  complex  (16)  and  the 
MBP peptides  fore1 short-lived peptide-MHC  complexes 
(20, 21). Evidently, the interaction ofpeptide-MHC ligand 
with its specific TCt< at the cell-cell interface does not sig- 
nificantly affect the rate of peptide loss.  Peptide and MHC 
side-chains  recognized  by  the  TCR  are  exposed  at  the 
membrane  distal  face  of the  MHC  protein  (22).  Presum- 
ably the  TCR, binds  to this  surface forming a  complex in 
which  the  peptide  is  sandwiched  between  the  MHC  and 
TCR  protein  surfaces.  Since  dissociation  of peptide  from 
this  TCR.-ligand  complex is  likely to be  slow  relative  to 
dissociation from free MHC, we assume that peptide disso- 
ciates primarily from MHC  not bound to a TCt<  (Fig.  4). 
Thus,  we attribute  the  decay in acidification observed for 
the  MBP  peptides  (Fig.  3  b)  to  rapid  dissociation  of the 
peptide-MHC  ligand  from the  TCR,  followed by subse- 
quent dissociation of the peptide from the MHC. 
To confirm that acid release observed after peptide addi- 
tion  reflects  active  TCR  triggering,  the  I-Ak-specific  10- 
2.16  antibody  (23)  was  added  to  previously  activated  T 
cells  at different times  after removal of peptide.  The rapid 
decreases in acid production after each addition of antibody 
(Fig.  3  c)  demonstrates  that  the  sustained  response  to  the 
MBP Ac(1-14)4A peptide is due to the continued presence 
ofpeptide-MHC complexes. In addition, the residual acid- 
ification  rate  observed  upon  completion  of the  antibody 
blockade is independent of when antibody was added (Fig. 
3 c). Thus, the gradual decrease in acid production seen af- 
ter peptide removal (Fig. 3, b and c) is most likely related to 
the loss ofpeptide as it dissociates from MHC protein.  We 
also added MBP Ac(1-14)4A peptide for 2  h  (as compared 
to the 30 min in Fig. 3  c) to determine  whether these ob- 
servations are sensitive to the duration of T  cell activation. 
The  rate  of decrease  in  acid  production  as  peptide  was 
washed  away  after  the  prolonged  peptide  exposure  was 
identical to that observed in Fig. 3 c (data not shown). 
The decrease  in acid production after MBP peptide  re- 
moval can be related  to the  rate  of dissociation of peptide 
from MHC  at the  cell-cell interface.  We observe that the 
increase  in  acid  release  from  activated  T  cells  is  propor- 
tional  to  the  logarithm  of peptide  concentration  over  a 
100-fold concentration range (Figs.  1 b and 3 a).  The MBP 
Ac(1-14)4A  concentration  used  for  the  experiments  de- 
scribed  in  Fig.  3,  b and c is in the  log-linear range  of this 
dose  response.  We  assume  that  the  observed  logarithmic 
dependence  of acidification  on peptide  concentration  im- 
plies a logarithmic dependence  on the amount of peptide- 
MHC ligand bound by TCRs. For MBP Ac(1-14)4A con- 
centrations  10  nM<  [P]  <  10  i~M,  the  acidification  (A) 
follows  the  empirical  relation  A  =  B  +  C  log([P]/P  ~ 
where B  and C  =  empirical constants,  [P]  =  peptide con- 
centration  (nM)  and P~ =  1 nM. Note that A  is defined as 
the acidification rate normalized to the maximum observed 
acidification.  The  slope  of the  dose  response  for  MBP 
Ac(1-14)4A gives C  =  34% (Fig. 3 a) . We assume that the 
concentration  of peptide-MHC,  [PM],  is  proportional  to 
added  peptide,  i.e.,  [PM]  =  ix  [P].  The  concentration  of 
peptide-MHC at time t as peptide dissociates from MHC is 
[PM]t =  Pmi e -kt where k  =  peptide dissociation rate con- 
T  Cell 
liiiii  .................  ..............  iii t 
APC 
Figure  4.  TCR-ligand  interactions at  the  cell-cell interface. The 
TCR-ligand complex (TCR-PM) initiates biochemical signals that cause 
increased acid release. Dissociation of the trimolecular complex gives free 
TCR and peptide-MHC  ligand (PM) which subsequently dissociates to 
give free peptide (~ and MHC. Biochemical signals leading to increased 
acid release terminate after TCR_-ligand dissociation. If peptide dissocia- 
tion from PM is fast relative to dissociation from TCR-PM, the rate at 
which peptide is lost from the T cell-APC interface is approximately the 
intrinsic peptide-MHC dissociation rate multiplied by the fraction of free 
peptide-MHC ligands: i.e., ko6  ~  = k,,~,: (PM)/(PM + TCR-PM). 
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the acidification during peptide dissociation is A  =  D  +  C 
log(e -kt) where D  =  B  +  C  log(PMi/o~ po). Therefore, the 
decay in acidification during peptide dissociation should be 
linear  with  respect  to  time  as  observed  for  MBP  Ac(1- 
14)4A  in  Fig.  3,  b  and  c.  From  six  different  experiments 
with  MBP  Ac(1-14)4A  we  calculate  an  average  slope  of 
0.38  +  0.08% min -1 which gives peptide dissociation rates 
with tl/2  =  27 +  6 min. 
The rate MBP Ac(1-14)4A peptide loss can be related to 
the apparent TCR-ligand affinity. We assume that the rate 
at  which  peptide  dissociates  from  the  TCP,-ligand  com- 
plex  is  slow  relative  to  dissociation  from  free  peptide- 
MHC.  Thus,  the  observed rate of peptide loss from the T 
cell-APC  interface  is  approximately  the  intrinsic  peptide- 
MHC  dissociation  rate  multiplied  by the  fraction  of free 
peptide-MHC ligands (Fig. 4). Since the tl/2 of dissociation 
for MBP Ac(1-14)4A from I-A  k in the absence ofT cells is 
30 min  (21)  (K.  Tate and P.P. Jones,  unpublished  results), 
we  infer  that  no  more  than  20%  of the  peptide--MHC 
complexes are TCR. bound at any one time.  Higher frac- 
tional  receptor  occupancies  might  have  been  anticipated 
given that TCR-ligand  affinities  measured in solution  are 
about 0.1-40  IxM (3-7) and the large number of TClks at 
the  cell-cell  interface  corresponds to an  effective concen- 
tration of ~30  b~M (24). 
Because  of the rapid loss of the native MBP(1-14)  pep- 
tide, the acidification response is below the log-linear range 
within  ~10  min  (Fig.  3  b).  From  the  initial  acidification 
slopes  (~10 min)  during loss of the native MBP Ac(1-14) 
peptide,  we estimate rates that correspond to a peptide dis- 
sociation tl/2  =  1-2 min. However, the rate of acidification 
decrease upon antibody addition (Fig. 3 b) also corresponds 
to an apparent TCR-ligand dissociation tl/2  of 1-2 rain.  In 
addition,  the  changes  in  steady state  signaling  (Fig.  2)  are 
also limited  by some process with  tl/2  of 1-2  min.  These 
observations demonstrate  that some event other than pep- 
tide  dissociation  with  tl/2  of 1-  2  min  is  associated  with 
changes in TCI< ligation and acid release.  It is possible that 
this is an intracellular biochemical process that mediates the 
triggering  of a  TCR.  and  acid  release. The  rate  limiting 
event could also be dissociation  of the  TCR-ligand com- 
plex.  In  either  case,  dissociation  of  the  peptide-MHC 
ligand from the TCR  at the interface of living cells  occurs 
at a rate in which tl/2  ~<1-2 min. We note that Valitutti et 
al.  have shown that  TCR.  epitopes  present  on T  cells  are 
lost during T  cell activation by a process with a lifetime on 
the order of 1-2 min (19). 
Although  TCP,-ligand  affinities  measured  for  isolated 
molecules  in  solution  are low  (3-7),  one  might have  ex- 
pected  enhanced  apparent  affinities  at  the  cell-cell  inter- 
face.  Membrane  bound  ligands  and  receptors  have  re- 
stricted  degrees  of  freedom  as  compared  to  those  in 
solution and TCR.-ligand reactions are associated with ad- 
ditional  coreceptor and adhesion  molecules  (1).  The local 
concentration  of TCR.s  is  also  expected  to be large  since 
they accumulate as  dense  clusters  at  the  cell-cell  interface 
(25). However, the cell-cell interface is a dynamic environ- 
ment due to cytoskeletal movements during T  cell activa- 
tion (26). Since proteins involved in T  cell signaling are as- 
sociated  with  the  cytoskeleton  (27),  it  is  likely  that 
cytoskeletal  motions  will  affect  the  TCR-ligand  binding 
and  dissociation reactions.  Despite  these  complexities,  our 
analysis  of T-cell  triggering  indicates  that  these  reactions 
can be described simply in terms of rapid, reversible bimo- 
lecular reactions.  We estimate  that only a fraction (<20%) 
of peptide-MHC  ligands are bound to a TCR. at any one 
time.  Thus,  in  those  cases  where  T  cells  are  activated  by 
50-200  ligands  (28),  only a  small  number  of ligands  (i.e., 
10)  may be actively engaged at any moment. These results 
support the emerging view that specific cellular recognition 
can be mediated by a small number of weak,  transient  re- 
ceptor-ligand interactions at the cell-cell interface. 
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